Legal Opinion
Sanofi-Aventis v. Apotex Inc.
District Court, S.D. New York
Decided October 19, 2010No. 02 Civ. 2255 (SHS)PublishedCited by 3 opinions
1Opinion of the Court
OPINION & ORDER
SIDNEY H. STEIN, District Judge.
Plaintiffs Sanofi-Aventis, Sanofi-Synthelabo Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, “Sanofi”) seek summary judgment on the issue of damages in this patent dispute concerning the drug Plavix. Because defendants Apotex Inc. and Apotex Corp. (collectively, “Apotex”) are liable to Sanofi for fifty percent of a net sates figure that the parties agree is $884,418,724, Sanofi’s motion for $442,209,362 in damages is granted. Sanofi is also entitled to interest and costs pursuant to 35 U.S.C. section 284.
I.…
2Cases cited11 opinions
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Kaiser Aluminum & Chemical Corp. v. BonjornoSupreme Court of the United States · 1990
- General Motors Corp. v. Devex Corp.Supreme Court of the United States · 1983
- Sanofi-Synthelabo v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2006
- Uniroyal, Inc. v. Rudkin-Wiley Corporation, Defendant/cross-Appellant. Premix, Inc. v. Rudkin-Wiley Corporation, Defendant/cross-AppellantCourt of Appeals for the Federal Circuit · 1991
6 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- Sanofi-Aventis v. Apotex Inc.Court of Appeals for the Federal Circuit · 2011
- Sanofi-Aventis v. Apotex Inc.Court of Appeals for the Federal Circuit · 2011
- Sanofi-Aventis v. Apotex Inc.Court of Appeals for the Federal Circuit · 2011